
This week’s round-up includes two pieces continuing to expand the views on how machine learning and artificial intelligence can affect cardiac care, as well as an update on the ORION-1 trial, and a negative link between non-steroidal anti-inflammatory drug (NSAIDs) and hypertension in a specific patient population.
Machine Learning Speeds Up Cardiac MRI Assessments
A new study showed that automated machine learning sped up the assessment of cardiac MRI. How fast is fast? The researchers, publishing in the Journal of the American Heart Association, reported that automated cardiac MRI analysis was performed 186x faster than would have been performed by human readers.